Voyager Therapeutics
VYGR
#7392
Rank
ยฃ0.24 B
Marketcap
ยฃ4.47
Share price
-9.32%
Change (1 day)
-18.65%
Change (1 year)

Revenue for Voyager Therapeutics (VYGR)

Revenue in 2024 (TTM): ยฃ0.11 Billion

According to Voyager Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ0.11 Billion. In 2023 the company made a revenue of ยฃ0.19 Billion an increase over the revenue in the year 2022 that were of ยฃ33.81 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Voyager Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.11 B-42.26%
2023 ยฃ0.19 B480.38%
2022 ยฃ33.81 M21.99%
2021 ยฃ27.71 M-77.92%
2020 ยฃ0.12 B57.7%
2019 ยฃ79.6 M1226.31%
2018 ยฃ6 M-19.95%
2017 ยฃ7.49 M-34.94%
2016 ยฃ11.52 M-1.48%
2015 ยฃ11.69 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA